Manuka honey may ease eczema symptoms for some people, but the evidence is too thin to call it proven, and it should never replace treatments your clinician prescribes. Small human trials and lab studies point to real antimicrobial and anti-inflammatory activity, which is promising but not conclusive. The sections below cover what the studies found, how the honey might work, and how to try it safely if you and your clinician decide it’s worth a shot.
TL;DR:
- Small studies suggest Manuka honey might improve eczema lesions temporarily, but larger, controlled trials have shown inconsistent results.
- The antimicrobial properties linked to methylglyoxal in honey have not demonstrated significant reductions in skin bacteria during eczema flares.
- Laboratory evidence indicates honey could support skin barrier proteins like filaggrin, but this has not been proven effective in clinical settings.
- Medical-grade Manuka honey is the safest option to minimize infection risks, and patch testing is essential before trialing it on any skin.
- It should only complement, not replace, standard treatments such as moisturizers and corticosteroids prescribed by a healthcare professional.
Table of Contents
- What the clinical studies on Manuka honey and eczema found
- How Manuka honey might affect eczema-prone skin
- How to try topical Manuka honey safely
- Where honey fits alongside standard eczema treatment
- Our take on formulating with Manuka honey
- A researched option if you want a barrier-focused routine
- Sources
- FAQ
What the clinical studies on Manuka honey and eczema found
The human evidence on Manuka honey for atopic dermatitis is real but limited in scale. A 2017 pilot study had 14 adults apply Manuka honey overnight to one eczema lesion for seven consecutive nights while leaving a matched lesion untreated. Treated lesions showed improvement on a standard severity score, but the study had no large control arm and short follow-up, so the results are suggestive rather than definitive.

A separate randomized controlled trial of Kanuka honey, a related New Zealand honey, tested medical-grade honey against aqueous cream in 15 adults over two weeks. It confirmed the approach was feasible and reasonably well tolerated, but honey did not outperform the control cream on lesion severity. That result matters: it’s one of the only honey-versus-control comparisons in eczema, and it came back neutral.
More recent lab work, including the 2023 mechanistic report in the British Journal of Dermatology, strengthens the biological rationale without adding new clinical proof. Taken together, the research supports these conclusions:
- Small pilot data suggest topical Manuka honey can improve treated lesions in some adults over a short trial period.
- A randomized trial using a related honey type did not show superiority over a standard moisturizer.
- Cell and mouse studies from 2023 explain plausible mechanisms but were not conducted in people with eczema.
- No large, well-controlled human trial has confirmed Manuka honey as an effective eczema treatment on its own.
The honest summary: this is hypothesis-generating evidence. It justifies further research, not a confident recommendation.
How Manuka honey might affect eczema-prone skin
Two mechanisms come up most often in the research. The first is antimicrobial: Manuka honey contains methylglyoxal (MGO), a compound tied to its antibacterial activity, and researchers have proposed it could reduce Staphylococcus aureus on skin, a bacteria often elevated during eczema flares. Interestingly, the 2017 pilot study did not find a significant change in skin staph levels among participants, which complicates that theory.
The second mechanism is anti-inflammatory and barrier-related. The BJD 2023 report found that low-concentration Manuka honey reduced IL-4-induced CCL26 signaling and increased filaggrin expression in cultured human keratinocytes.
Filaggrin is a protein central to skin barrier function, and low filaggrin activity is a known feature of atopic dermatitis. That mechanistic finding offers a plausible reason honey might help, though cell-culture results cannot be translated directly into a human dose or treatment duration.
It’s also worth separating honey types. Medical-grade Manuka honey, used in wound-care products, is processed and standardized. Kitchen honey is not sterilized to the same standard and can carry bacterial spores, which matters for anyone applying it to broken or inflamed skin.
How to try topical Manuka honey safely
If you want to experiment with Manuka honey, treat it like you would any new topical product on compromised skin: cautiously and with an exit plan.
- Choose a medical-grade Manuka honey product or an FDA-cleared option like Medihoney, which holds 510(k) clearance for topical wound care, rather than honey from your pantry.
- Patch-test on a small area of intact skin and wait 24 to 48 hours before applying it to an eczema patch.
- Apply a thin layer to one affected, unbroken area, cover with non-adherent gauze overnight, and wash off in the morning.
- Watch for itching, burning, swelling, hives, or spreading redness, and stop immediately if any appear.
- Avoid using honey on weeping, infected, facial, or periocular eczema without a clinician’s direction.
No validated regimen exists for frequency or duration, so treat any trial as short-term and informal rather than a set protocol. People with a known bee product or pollen allergy face a real risk of allergic reaction, including anaphylaxis in rare cases, so anyone with that history should skip topical honey entirely and seek emergency care if a severe reaction occurs.
Pro Tip: Apply honey to just one lesion at first so you can compare it against an untreated patch, the same approach researchers used in the 2017 pilot study.
Where honey fits alongside standard eczema treatment
Topical Manuka honey is, at best, a complementary step, not a substitute for first-line eczema care. The American Academy of Dermatology’s updated guidance centers treatment on consistent moisturizer use plus clinician-directed anti-inflammatory medication when needed.
- Regular emollient use is foundational and recommended for all eczema severity levels.
- Topical corticosteroids remain the fastest, best-supported way to control active inflammation during a flare.
- Calcineurin inhibitors, crisaborole, and short-course ruxolitinib are additional options your clinician may prescribe depending on your case.
- Honey has not been shown to control inflammation as reliably as these treatments, so it should not replace them.
If you decide to try Manuka honey, keep using your prescribed regimen and tell your clinician what you’re adding. Stopping medication to try a home remedy risks a worse flare with no guarantee of benefit in return.
Our take on formulating with Manuka honey

At CKYN, we treat Manuka honey as one supporting ingredient in a barrier-focused system, not a stand-alone eczema fix. Our copper peptide protocol pairs it with GHK-Cu and grass-fed tallow at concentrated levels, built around the idea that fewer, higher-concentration ingredients reduce the irritation risk that comes with crowded formulas. We source Manuka honey with medical-grade handling in mind to ensure consistency, as skin with a compromised barrier can react poorly to inconsistency.
This approach is about hydration and barrier support generally. It isn’t a claim that our products treat eczema, and anyone managing active atopic dermatitis should keep following their clinician’s plan.
— Garrick
A researched option if you want a barrier-focused routine
If the evidence above has you interested in how Manuka honey performs alongside other barrier-supporting ingredients, This three-step protocol combines a morning lotion, a daytime tallow balm, and a nighttime serum, each formulated with copper peptides, Manuka honey, and grass-fed tallow at concentrated levels rather than long ingredient lists.

- Fragrance-free formulas designed for people who want fewer, higher-concentration actives instead of filler ingredients.
- A three-step routine covering morning hydration, daytime protection, and nighttime repair.
- Built for general skin barrier support and visible texture improvement, not as an eczema treatment.
If you have active eczema or another diagnosed skin condition, talk to your clinician before adding any new product or changing your current treatment. You can see the full GHK-Cu protocol and each product’s ingredients before deciding if it fits your routine.
Sources
- Honey is potentially effective in the treatment of atopic dermatitis: Clinical and mechanistic studies
- A randomised controlled trial of topical Kanuka honey for the treatment of eczema
- British Journal of Dermatology mechanistic report (2023)
- American Academy of Dermatology — updated atopic dermatitis guidance
- 510(k) Summary for Medihoney dressings (Derma Sciences)
FAQ
Can I put Manuka honey on my eczema?
You can try it on intact, unbroken skin after a patch test, but avoid open, weeping, or infected lesions. Choose medical-grade Manuka honey rather than kitchen honey, and stop immediately if you notice itching, burning, or spreading redness.
Does Manuka honey actually work on eczema?
The evidence is mixed: a small 2017 pilot study found improvement in treated lesions, while a randomized trial of Kanuka honey found no advantage over a standard moisturizer. Both studies were small, so the honest answer is that it may help some people but isn’t proven.
What heals eczema the fastest?
Topical corticosteroids prescribed by a clinician remain the fastest way to control an active flare, according to AAD guidance, alongside consistent daily moisturizer use. Natural remedies like honey may support skin comfort but have not matched corticosteroids for speed of inflammation control.
Is raw kitchen honey safe to use on eczema?
Raw kitchen honey isn’t processed to the same standard as medical-grade products and can carry bacterial spores that pose a risk to compromised skin. Medical-grade Manuka honey or an FDA-cleared product like Medihoney is the safer choice for topical use.
How often should I apply Manuka honey to eczema patches?
No validated schedule exists, so any trial should stay short and closely monitored rather than following a fixed routine. A cautious approach used in research involved a thin nightly layer on one lesion for about a week, covered with gauze and washed off each morning.